vectibix 100 mg vial

Vectibix is a targeted anticancer medication used in the treatment of certain types of colorectal cancer. It contains panitumumab as its active ingredient, a monoclonal antibody that works by blocking the epidermal growth factor receptor (EGFR), thereby inhibiting the growth and spread of cancer cells.

The medication is administered by intravenous infusion in a hospital setting under the supervision of healthcare professionals. It is used to help control the progression of advanced or metastatic colorectal cancer and is an important treatment option for patients who require targeted biological therapy.

Vectibix Ingredients

• Panitumumab.

Vectibix Strengths

Vial containing 100 mg/5 mL.

Vial containing 400 mg/20 mL.

Uses of Vectibix

• Treatment of advanced or metastatic colorectal cancer.

• Inhibition of epidermal growth factor receptor (EGFR) activity that promotes tumor growth.

• Use as monotherapy or in combination with chemotherapy.

• Slowing the growth and proliferation of malignant cancer cells.

Vectibix Dosage

The usual recommended dose is 6 mg/kg of body weight administered once every 14 days by intravenous infusion under medical supervision. The infusion typically lasts between 60 and 90 minutes. Your physician may adjust the dose according to your response to treatment, tolerance, and the occurrence of adverse effects.

Side Effects of Vectibix

• Skin rash, itching, and dry skin.

• Fatigue and general weakness.

• Diarrhea or other gastrointestinal disturbances.

• Low blood magnesium levels.

• Nail changes or inflammation around the nails.

• Nausea and decreased appetite.

Contraindications of Vectibix

Vectibix should not be used in patients with severe hypersensitivity to panitumumab or any of the product's ingredients. It is also contraindicated in patients with certain RAS gene mutations, as studies have shown that the medication is ineffective and may be harmful in these cases.

Treatment should also be avoided in patients with severe interstitial lung disease, pulmonary fibrosis, or uncontrolled severe hypomagnesemia. The medication should not be used during pregnancy or breastfeeding unless the potential benefit clearly outweighs the potential risks, as determined by the treating physician.

Vectibix Alternatives

• Vectibix.

• Erbitux.

• Avastin.

How to Use Vectibix Correctly

Vectibix should be prepared and administered only by trained healthcare professionals. The solution must be diluted with sodium chloride solution before intravenous infusion. The vial should not be shaken during preparation to avoid foam formation.

Patients are advised to use skin moisturizers and sunscreen to help reduce skin-related side effects. Regular medical evaluations and laboratory tests should be performed before each dose to monitor treatment safety and effectiveness.

Storage Conditions

• Store refrigerated at 2°C to 8°C.

• Do not freeze.

• Keep the vial in its original carton to protect it from light.

• Keep out of the reach and sight of children.